Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “BOARD OF REGENTS”

2,639 pharma patents match "BOARD OF REGENTS" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,639
Index total 30,257
Page 67 / 110

Quick answer

This filtered view shows 2,639 pharmaceutical patents matching "BOARD OF REGENTS" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,639 results for “BOARD OF REGENTS” · 30,257 patents in full index Clear search

  1. US 8901095

    Selective inhibition of polyglutamine protein expression

    The Board of Regents of the University of Texas System · Granted Dec 2, 2014 · Expires Nov 27, 2034

    granted

  2. US 8895717

    Delivery of siRNA by neutral lipid compositions

    The Board of Regents of the University of Texas System · Granted Nov 25, 2014 · Expires Nov 20, 2034

    granted

  3. US 8895072

    Quantum dot barcode structures and uses thereof

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Nov 25, 2014 · Expires Nov 20, 2034

    granted

  4. US 8889743

    Inhibition of filovirus entry into cells and uses thereof

    The Board of Regents of the University of Texas System · Granted Nov 18, 2014 · Expires Nov 13, 2034

    granted

  5. US 8889121

    Bacterium comprising a regulated rfaH nucleic acid

    The Arizona Board of Regents for an on Behalf of Arizona State University · Granted Nov 18, 2014 · Expires Nov 13, 2034

    granted

  6. US 8889623

    Immunostimulatory nanoparticles and related compositions, methods and systems

    The Board of Regents of the University of Texas System · Granted Nov 18, 2014 · Expires Nov 13, 2034

    granted

  7. US 8883729

    Nanolipoprotein particles and related compositions, methods and systems

    The Board of Regents of the University of Texas System · Granted Nov 11, 2014 · Expires Nov 6, 2034

    granted

  8. US 8883154

    Antibody-mediated modulation of allergy

    The Board of Regents of the University of Texas System · Granted Nov 11, 2014 · Expires Nov 6, 2034

    granted

  9. US 8883841

    Oncogenic ras-specific cytotoxic compound and methods of use thereof

    The Board of Regents of the University of Texas System · Granted Nov 11, 2014 · Expires Nov 6, 2034

    granted

  10. US 8883174

    Compositions for stimulation of mammalian innate immune resistance to pathogens

    The Board of Regents of the University of Texas System · Granted Nov 11, 2014 · Expires Nov 6, 2034

    granted

  11. US 8877188

    Detection and treatment of non-dermal fibrosis

    The Board of Regents of the University of Texas System · Granted Nov 4, 2014 · Expires Oct 30, 2034

    granted

  12. US 8877797

    Methods for treating Parkinson's disease using pro-neurogenic compounds

    The Board of Regents of the University of Texas System · Granted Nov 4, 2014 · Expires Oct 30, 2034

    granted

  13. US 8877215

    Compounds with modifying activity enhanced under hypoxic conditions

    The Board of Regents of the University of Texas System · Granted Nov 4, 2014 · Expires Oct 30, 2034

    granted

  14. US 8871794

    Small-molecule agonists for type-2 orexin receptor

    The Board of Regents of the University of Texas System · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted

  15. US 8865199

    Biomatrix composition and methods of biomatrix seeding

    The Board of Regents of the University of Texas System · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  16. US 8865187

    Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity

    The Board of Regents of the University of Texas System · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  17. US 8859727

    Bioactive FUS1 peptides and nanoparticle-polypeptide complexes

    The Board of Regents of the University of Texas System · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  18. US 8859736

    Monoclonal antibodies that inhibit the wnt signaling pathway and methods of production and use thereof

    The Board of Regents of the University of Oklahoma · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  19. US 8846006

    MRI markers, delivery and extraction systems, and methods of manufacture and use thereof

    The Board of Regents of the University of Texas System · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  20. US 8846859

    Compositions and methods of use of targeting peptides against placenta and adipose tissues

    The Board of Regents of the University of Texas System · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  21. US 8841273

    Methods and compositions for anti-EGFR treatment

    The Board of Regents of the University of Texas System · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted

  22. US 8841257

    Inhibitors of STAT3 and uses thereof

    The Board of Regents of the University of Texas System · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted

  23. US 8834938

    Use of arsenic for cancer therapy protection

    The Board of Regents of the University of Texas System · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  24. US 8835491

    Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.